PDC and chronic myelomonocytic leukemia: Several patients, for whom a borderline DNA methylation profile between AML and BPDCN was identified, were found to resemble cases with either syn- or metachronous development of CMML/AML or a molecular and phenotypical constellation resembling AML with pDC-like features [9, 10].